NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ProArc Medical

ProArc Medical

Private
IsraelHealthcare & Life Scienceshttps://www.proarcmedical.com/

Last Round

SAFE

Jul 1, 2026

Total Funding Raised

$2.2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

ProArc Medical is a medical device company that develops minimally invasive solutions for the treatment of benign prostatic hyperplasia (BPH).

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical deviceurologybenign prostatic hyperplasiaBPHminimally invasive surgeryurological implantsmen's healthsurgical platformurology devicemedtechnitinol implanturology clinicambulatory surgery centerprostate treatment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ProArc Medical Comparables

Compare ProArc Medical with similar companies based on industry and business-model similarity.

ProArc Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Prodeon Medical
89%
Butterfly Medical
88%
Zenflow
88%

ProArc Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SAFEJul 1, 2026
Series AMay 1, 2023
GrantJul 2, 2019

Key People

Founding team and executive leadership

Gilad Hizkiyahu

Chief Executive Officer

Executive Team

ProArc Medical Investors

Notable investors and investment history

ProArc Medical investors
InvestorRounds
Horizon 2020Grant
The Trendlines GroupSAFE

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 3, 2026

    Monthly visitors grew 536% MoM, reaching 1.3K.

ProArc Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ProArc Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ProArc Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Employee Range7
Year Founded2010
Last FundingJul 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.